Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
996.8 GBX | +1.14% | +1.61% | -7.58% |
May. 03 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
May. 02 | Deutsche Bank likes TP ICAP but says sell CMC | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.58% | 10.91B | A- | ||
+2.17% | 8.93B | C | ||
+22.75% | 7.57B | C | ||
+33.99% | 5.34B | B+ | ||
+8.12% | 3.43B | C- | ||
-8.48% | 2.81B | B- | ||
-5.07% | 2.23B | - | - | |
-4.22% | 2.13B | - | ||
-20.87% | 1.84B | - | C- | |
-4.52% | 1.2B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SN. Stock
- Ratings Smith & Nephew Plc